CDMO241220C17500
- 0.00
- 0.000.00%
Avid Bioservices Newsroom
Vetter Strengthens Senior Management Team for Further Sustainable Growth
GBI Biomanufacturing Expands Capabilities With Automated Aseptic Fill-Finish for Drug Products
Avid Bioservices Gains as Holder Opposes $12.50 a Share Takeover
Punch and Assocs: Own About 4.5% of Avid Shares Outstanding
Punch and Assocs: Believe the Offer Materially Undervalues Avid
Express News | Punch and Associates: Intends to Vote Against Proposed Acquisition of Avid Bioservices by Gho Capital and Ampersand Capital
Punch and Associates Sends Letter to Board of Directors of Avid Bioservices, Inc.
Express News | Brock Pond Capital Partners: Urges Avid Bioservices to Remain Standalone Public Company Absent Improved Offer
Shareholder Alert: Ademi LLP Investigates Whether Avid Bioservices, Inc. Is Obtaining a Fair Price for Its Public Shareholders
ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Avid Bioservices, Inc.
Craig-Hallum Maintains Avid Bioservices(CDMO.US) With Buy Rating
Express News | Avid Biosciences Shares Are Trading Higher After the Company Announced It Agreed to Be Acquired by GHO Capital Partners and Ampersand in a $1.1 Billion Transaction. Also, RBC Capital Raised Its Price Target on the Stock From $12 to $12.5
Avid Bioservices Downgraded to Hold From Buy at Craig-Hallum
GHO and Ampersand Capital to Acquire Avid Bioservices
Avid Bioservices to Be Acquired in $1.1 Billion Deal
Here's Why Avid Bioservices (NASDAQ:CDMO) Can Afford Some Debt
RBC Capital Downgrades Avid Bioservices(CDMO.US) to Hold Rating, Raises Target Price to $12.5
Express News | William Blair Reiterates Market Perform on Avid Bioservices
Avid Bioservices Analyst Ratings
Express News | Avid Bioservices Inc : RBC Cuts to Sector Perform From Outperform